Abstract:Huntington disease (HD) is an inherited neurodegenerative disorder affecting movement, mood and cognition, and striatal neurons show highest vulnerability to dysfunction and death. Calcium, a key messenger for transmitting external stimuli to the cell's nucleus, helps coordinate new protein expression that ultimately regulates neuronal health and connectivity in the brain. Here, we use a model system to explore the mechanisms of calcium signalling to the nucleus in striatal neurons, revealing critical roles for N‐methyl‐D‐aspartate receptors and ryanodine receptors, and demonstrating early impairment in this pathway in HD. Huntington's disease (HD) is a monogenic disorder with autosomal dominant inheritance. In HD patients, neurons in the striatum and cortex degenerate, leading to motor, psychiatric and cognitive disorders. Dysregulated synaptic function and calcium handling are common in many neurodegenerative diseases, including HD. N‐methyl‐D‐aspartate (NMDA) receptor function is enhanced in HD at extrasynaptic sites, altering the balance of calcium‐dependent neuronal survival versus death signalling pathways. Endoplasmic reticulum (ER) calcium handling is also abnormal in HD. The ER, which is continuous with the nuclear envelope, is purportedly involved in nuclear calcium signalling; based on this, we hypothesised that nuclear calcium signalling is altered in HD. We explored this hypothesis with calcium imaging techniques, including simultaneous epifluorescent imaging of cytosolic and nuclear calcium using jRCaMP1b and GCaMP3 sensors, respectively, in striatal spiny projection neurons in cortical–striatal co‐cultures from the YAC128 mouse model of HD. Our data show contributions from a variety of calcium channels to nuclear calcium signalling. NMDA receptors (NMDARs) play an essential role in initiating action potential‐dependent calcium signalling to the nucleus, and ryanodine receptors (RyR) contribute to both cytosolic and nuclear calcium signals. Unlike previous reports in glutamatergic hippocampal and cortical neurons, we found that in GABAergic striatal neurons, L‐type voltage‐gated calcium channels (CaV) contribute to cytosolic, but not nuclear calcium signalling. Calcium imaging also suggests impairments in nuclear calcium signalling in HD striatal neurons, where spontaneous action potential‐dependent calcium transients in the nucleus were smaller in YAC128 striatal neurons compared to those of wild‐type (WT). Our results elucidate mechanisms involved in action potential‐dependent nuclear calcium signalling in GABAergic striatal neurons, and have revealed a clear deficit in this signalling in HD.

Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington’s Disease

Enhanced Store-Operated Calcium Entry Leads To Striatal Synaptic Loss In A Huntington'S Disease Mouse Model

Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment

Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease

Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington’s Disease

Effect of chronic upregulation of endocannabinoid signaling in vivo with JZL184 on striatal synaptic plasticity and motor learning in YAC128 Huntington disease mice

Pharmacological Co-Activation of TrkB and TrkC Receptor Signaling Ameliorates Striatal Neuropathology and Motor Deficits in Mouse Models of Huntington's Disease

Presymptomatic Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis

Alterations in STriatal‐Enriched Protein Tyrosine Phosphatase Expression, Activation, and Downstream Signaling in Early and Late Stages of the YAC128 Huntington's Disease Mouse Model

Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice

Mechanisms of synapse‐to‐nucleus calcium signalling in striatal neurons and impairments in Huntington's disease

Store-operated calcium channel complex in postsynaptic spines: A new therapeutic target for alzheimer’s disease treatment

Enhanced Na+-K+-2Cl(-) Cotransporter 1 Underlies Motor Dysfunction in Huntington's Disease

Impaired Ubiquitin–proteasome System Activity in the Synapses of Huntington's Disease Mice

Calpain and STriatal-Enriched Protein Tyrosine Phosphatase (STEP) Activation Contribute to Extrasynaptic NMDA Receptor Localization in a Huntington's Disease Mouse Model.

Reduced Lysosomal Density in Neuronal Dendrites Mediates Deficits in Synaptic Plasticity in Huntington’s Disease

Potassium channel dysfunction in neurons and astrocytes in Huntington's disease

Restoring Compromised Cl- in D2 Neurons of a Huntingtons Disease Mouse Model Rescues Motor Disability

A Striatal-Enriched Intronic GPCR Modulates Huntingtin Levels and Toxicity

Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington’s disease

TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs.